Your browser doesn't support javascript.
loading
Peripheral blood kinetics following total body irradiation and allogeneic hematopoietic stem cell transplantation: Timing matters.
Dejonckheere, Cas S; Böhner, Alexander M C; Schmitz, Eva; Holderried, Tobias A W; Schmeel, Leonard C; Brossart, Peter; Giordano, Frank A; Köksal, Mümtaz A.
Afiliação
  • Dejonckheere CS; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
  • Böhner AMC; Institute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
  • Schmitz E; Department of Neurology, University Hospital Bonn, Bonn, Germany.
  • Holderried TAW; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
  • Schmeel LC; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
  • Brossart P; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
  • Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
  • Köksal MA; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
Cancer Med ; 12(6): 7170-7174, 2023 03.
Article em En | MEDLINE | ID: mdl-36404470
ABSTRACT
Total body irradiation (TBI) remains an important component in many conditioning regimens before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because of its frequent toxicity, patient selection is crucial, making it of interest to identify factors improving engraftment. In this retrospective single center analysis, the characteristics of 48 adult such patients were studied. Mean overall survival (OS) was 22.2 months after allo-HSCT. Interestingly, people with an interval ≥3 days between TBI completion and allo-HSCT showed improved OS, when compared to a shorter interval (p = 0.10). Peripheral blood kinetics after successful engraftment also differed, with a longer interval resulting in a higher platelet count and lower leukocyte and neutrophil (p < 0.05) count. These data suggest that the exact timing of TBI before allo-HSCT might directly impact a patient's survival and could help single out those at higher risk of graft failure who might benefit from an altered conditioning regimen.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article